+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bladder Drug"

Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2025 - Product Thumbnail Image

Urinary Incontinence Including Neurogenic Bladder - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Underactive Bladder (UAB)- Epidemiology Forecast-2034 - Product Thumbnail Image

Underactive Bladder (UAB)- Epidemiology Forecast-2034

  • Report
  • December 2024
  • 70 Pages
  • Global
From
Solifenacin Succinate API Market - Global Forecast 2025-2030 - Product Thumbnail Image

Solifenacin Succinate API Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 198 Pages
  • Global
From
Overactive Bladder Treatment Market - Global Forecast 2025-2030 - Product Thumbnail Image

Overactive Bladder Treatment Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Overactive Bladder Treatment Market Report 2025 - Product Thumbnail Image

Overactive Bladder Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Pediatric Bladder Treatment Market Report 2025 - Product Thumbnail Image

Pediatric Bladder Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Darifenacin Hydrobromide Market Report: Trends, Forecast and Competitive Analysis to 2030 - Product Thumbnail Image

Darifenacin Hydrobromide Market Report: Trends, Forecast and Competitive Analysis to 2030

  • Report
  • November 2024
  • 150 Pages
  • Global
From
Overactive Bladder- Pipeline Insight, 2025 - Product Thumbnail Image

Overactive Bladder- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 271 Pages
  • Global
From
Overactive Bladder Therapeutics Market 2025-2029 - Product Thumbnail Image

Overactive Bladder Therapeutics Market 2025-2029

  • Report
  • May 2025
  • 221 Pages
  • Global
From
Overactive Bladder Treatment Market Report and Forecast 2025-2034 - Product Thumbnail Image

Overactive Bladder Treatment Market Report and Forecast 2025-2034

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Overactive Bladder Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Overactive Bladder Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Urinary Incontinence Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Urinary Incontinence Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027 - Product Thumbnail Image

Overactive Bladder Treatment (OAB) Market by Drug type ( Anticholinergic (Solifenacin, Oxybutynin, Tolterodine, Darifenacin), Mirabegron), Botox, Neuromodulation, Disease Type (Idopathic OAB and Neurogenic OAB) and Region - Global Forecasts to 2027

  • Report
  • July 2022
  • 203 Pages
  • Global
From
Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), Disease Type (Idiopathic, Neurogenic), Distribution Channel, Region, and Segment Forecasts, 2024-2030 - Product Thumbnail Image

Overactive Bladder Treatment Market Size, Share & Trends Analysis Report, Type (Anticholinergics, Mirabegron, Neuromodulation, Botox), Disease Type (Idiopathic, Neurogenic), Distribution Channel, Region, and Segment Forecasts, 2024-2030

  • Report
  • December 2023
  • 100 Pages
  • Global
From
Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030 - Product Thumbnail Image

Genitourinary Drugs Market Size, Share & Trends Analysis Report By Indication (Prostate, Ovarian, Bladder, Cervical Cancer, UTI & STD), By Product (Hormonal Therapy, Gynecological), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • September 2023
  • 110 Pages
  • Global
From
Overactive Bladder - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Overactive Bladder - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Urinary Incontinence Including Neurogenic Bladder - Epidemiology Forecast - 2032 - Product Thumbnail Image

Urinary Incontinence Including Neurogenic Bladder - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Overactive Bladder (OAB) - Epidemiology Forecast to 2032 - Product Thumbnail Image

Overactive Bladder (OAB) - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032 - Product Thumbnail Image

Genitourinary Drugs Market Report by Indication, Product, and Region 2024-2032

  • Report
  • August 2024
  • 142 Pages
  • Global
From
Loading Indicator

The Bladder Drug market is a subset of the Urological Disorders Drugs market, which focuses on treatments for conditions related to the urinary tract. These drugs are used to treat a variety of conditions, including urinary incontinence, overactive bladder, bladder cancer, and urinary tract infections. Bladder drugs are typically administered orally, topically, or through injections. Commonly prescribed bladder drugs include anticholinergics, antispasmodics, and alpha-blockers. The Bladder Drug market is highly competitive, with a range of generic and branded products available. Companies in the market include Astellas Pharma, Allergan, Pfizer, Merck, and Sanofi. Show Less Read more